125 related articles for article (PubMed ID: 7513623)
1. Evidence that GYKI 52466, a novel non-NMDA antagonist enhances the decay of kainate-induced current in cultured chicken cortical neurons.
Osipenko O; Mike A; Gyevai A; Vizi ES
Brain Res Dev Brain Res; 1994 Feb; 77(2):257-63. PubMed ID: 7513623
[TBL] [Abstract][Full Text] [Related]
2. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
3. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
4. GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM
Neurosci Lett; 1993 Apr; 152(1-2):169-72. PubMed ID: 8100052
[TBL] [Abstract][Full Text] [Related]
5. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
[TBL] [Abstract][Full Text] [Related]
6. Kainate produces concentration-dependent elevation of glutamate release but not cGMP levels in cultured neuron.
Oh S; McCaslin PP
Gen Pharmacol; 1996 Jan; 27(1):83-7. PubMed ID: 8742499
[TBL] [Abstract][Full Text] [Related]
7. Excitatory amino acid-induced currents in rat septal cholinergic neurons in culture.
Kumamoto E; Murata Y
Neuroscience; 1995 Nov; 69(2):477-93. PubMed ID: 8552243
[TBL] [Abstract][Full Text] [Related]
8. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
Waters DJ; Allen TG
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine, with (S)- alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured rat cortical neurons: electrophysiological evidence for at least two different binding sites for non-competitive antagonists.
Weiser T; Herrmann A; Wienrich M
Neurosci Lett; 1996 Sep; 216(1):29-32. PubMed ID: 8892384
[TBL] [Abstract][Full Text] [Related]
10. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
Rammes G; Swandulla D; Spielmanns P; Parsons CG
Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
[TBL] [Abstract][Full Text] [Related]
11. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW; Noraberg J; Zimmer J
Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
[TBL] [Abstract][Full Text] [Related]
13. Ionotropic glutamate receptors in isolated horizontal cells of the rabbit retina.
Blanco R; de la Villa P
Eur J Neurosci; 1999 Mar; 11(3):867-73. PubMed ID: 10103080
[TBL] [Abstract][Full Text] [Related]
14. Activation and desensitization of hippocampal kainate receptors.
Wilding TJ; Huettner JE
J Neurosci; 1997 Apr; 17(8):2713-21. PubMed ID: 9092592
[TBL] [Abstract][Full Text] [Related]
15. A comparison of non-NMDA receptor channels in type-2 astrocytes and granule cells from rat cerebellum.
Wyllie DJ; Cull-Candy SG
J Physiol; 1994 Feb; 475(1):95-114. PubMed ID: 7514667
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
Wilding TJ; Huettner JE
Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics of non-NMDA-type ionotropic glutamate receptor channels in AII amacrine cells in rat retina.
Mørkve SH; Veruki ML; Hartveit E
J Physiol; 2002 Jul; 542(Pt 1):147-65. PubMed ID: 12096058
[TBL] [Abstract][Full Text] [Related]
18. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons.
Regan RF
Neurosci Lett; 1996 Jul; 213(1):9-12. PubMed ID: 8844700
[TBL] [Abstract][Full Text] [Related]
19. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.
Donevan SD; Rogawski MA
Neuron; 1993 Jan; 10(1):51-9. PubMed ID: 7678966
[TBL] [Abstract][Full Text] [Related]
20. Gamma-D-glutamylaminomethyl sulfonic acid (GAMS) distinguishes kainic acid- from AMPA-induced responses in Xenopus oocytes expressing chick brain glutamate receptors.
Zhou N; Hammerland LG; Parks TN
Neuropharmacology; 1993 Aug; 32(8):767-75. PubMed ID: 7692340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
